Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 1/20 | 0.63 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.63 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.63 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | CPT2 | P23786 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.39 |
| ▸ | ACLY | P53396 | 3/20 | 0.39 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| .Beta.-Hydroxyisovaleric Acid SCHEMBL723161 | 1.00 | — | — | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL5162719 | 0.97 | HMGCR (0.60) | HMGCRCHRM1TBXA2RADRA1ATSHR | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL95499 | 0.97 | — | — | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL5159910 | 0.94 | — | — | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL31058606 | 0.94 | — | — | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL2340215 | 0.94 | — | — | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL30764083 | 0.94 | — | — | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL30764122 | 0.94 | — | — | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL10277346 | 0.94 | — | — | |
| .Beta.-Hydroxyisovaleric Acid SCHEMBL925875 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-221246002-U | Raw material screening device for producing beta-hydroxy-beta-methyl calcium butyrate | 泰安盛和生物科技有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-220861566-U | Smashing device for calcium methylbutyrate production | 连云港盛和生物科技有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-116786020-B | Hot dissolving device for calcium methylbutyrate processing and preparation and application method thereof | 连云港瑞邦药业有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-117398760-B | Impurity separating device | 技源集团股份有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-220443788-U | Quantitative adding device for calcium methylbutyrate production | 连云港盛和生物科技有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-117398760-A | Impurity separating device | 技源集团股份有限公司 | 2024-01-16 | — | — | CN | disclosed |
| CN-116786020-A | Hot dissolving device for calcium methylbutyrate processing and preparation and application method thereof | 连云港瑞邦药业有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-215138700-U | Thermal dissolving device for processing and preparing beta-hydroxy-beta-methylbutyrate calcium | 连云港盛和生物科技有限公司 | 2021-12-14 | — | — | CN | disclosed |
| EP-2442675-A1 | NUTRITIONAL EMULSIONS COMPRISING CALCIUM HMB AND SOLUBLE PROTEIN | Abbott Laboratories (US) | 2012-04-25 | — | — | EP | disclosed |
| US-20110256301-A1 | Nutritional Emulsions Comprising Calcium HMB | ABBOTT LABORATORIES | 2011-10-20 | — | — | US | disclosed |
| US-20110256297-A1 | Nutritional Emulsions Comprising Calcium HMB and Soluble Protein | ABBOTT LABORATORIES | 2011-10-20 | — | — | US | disclosed |
| WO-2011094557-A1 | NUTRITIONAL EMULSIONS COMPRISING CALCIUM HMB | ABBOTT LABORATORIES (US) | 2011-08-04 | — | — | WO | disclosed |
| WO-2011094544-A1 | NUTRITIONAL EMULSIONS COMPRISING CALCIUM HMB AND SOLUBLE PROTEIN | ABBOTT LABORATORIES (US) | 2011-08-04 | — | — | WO | disclosed |